Fitterfly HealthTech Pvt Ltd Logo
< Back to Listing
Conference abstracts Conference abstracts
Real-world effectiveness of Diabefly® digital therapeutics program for improving glycemic control in people with Type 2 diabetes
Nov 2021 | Oral | By Dr Ritika Verma, Sanjay Kalra, Dr.Tejal Lathia , Nikhil Chitnis, Archana Juneja, Om Lakhani, Rabindra Das, Vandana Jain, Sonali Patange, Kirti Samudra, Vishal Kini, Dr. Snehal Tanna, Ashish Sarawte, Dr Arbinder Kumar Singal

Real-world effectiveness of Diabefly® digital therapeutics program for improving glycemic control in people with Type 2 diabetes

In developing countries, poor glycemic control among their diabetic population remains a major challenge. This study explored the potential of 90 days Diabefly® program towards improving glycemic control in people with type 2 diabetes and demonstrated an effective mean reduction of HbA1c, body weight and BMI by 1.63%, 2.38 kg, and 0.83 kg/m2 respectively. Thus, Diabefly® program aids in improving glycemic control and subsequently reduces the risk of diabetes-related complications.

Read full paper